APA (7th ed.) Citation

Puigvehí, M., De Cuenca, B., Viu, A., Diago, M., Turnes, J., Gea, F., . . . Moreno, J. (2019). Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild‐moderate fibrosis: Results from a real‐world cohort. Liver International, 39(1), 90. https://doi.org/10.1111/liv.13950

Chicago Style (17th ed.) Citation

Puigvehí, Marc, et al. "Eight Weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV Genotype 1b with Mild‐moderate Fibrosis: Results from a Real‐world Cohort." Liver International 39, no. 1 (2019): 90. https://doi.org/10.1111/liv.13950.

MLA (9th ed.) Citation

Puigvehí, Marc, et al. "Eight Weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV Genotype 1b with Mild‐moderate Fibrosis: Results from a Real‐world Cohort." Liver International, vol. 39, no. 1, 2019, p. 90, https://doi.org/10.1111/liv.13950.